Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Abatacept SC vs IV in Japanese RA Patients
NCT01001832Phase 3Completed
- Sponsor
- Bristol Myers Squibb
- Start
- Dec 2009
- Primary completion
- Feb 2011
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 3 trial of abatacept in rheumatoid arthritis (RA), sponsored by Bristol Myers Squibb. Started Dec 2009; status: completed.
02
Drugs
abatacept
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT01001832.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01001832.